Carelabs Q2 Sales Reach 23.9 Billion KRW, Up 32.2% YoY

[Asia Economy Reporter Hyunseok Yoo] Carelabs announced on the 13th through an earnings disclosure that its consolidated sales for the second quarter of this year reached 23.9 billion KRW, marking a 32.2% increase compared to the same period last year. Operating profit for the same period slightly decreased to 1.76 billion KRW.

The company emphasized that despite a temporary slowdown in profit growth in the second quarter due to one-time additional expenses arising from the business expansion of its consolidated subsidiaries, overall sales growth continued, mainly driven by profitable business sectors. Consolidated sales for the first half of this year reached 45.75 billion KRW, representing approximately 23.5% year-on-year growth, setting a record for the highest half-year sales since the company's founding.

Park Kyung-deuk, CEO of Carelabs, stated, “The health and beauty care non-face-to-face platform service, which has joined as a core business division driving performance, has entered a full-scale business expansion phase. Therefore, we expect rapid profit growth to follow the steep increase in sales going forward. Given the nature of the platform business, we plan to prepare various service improvement measures and expand the business scale through diversified investments to stay ahead of the rapidly changing domestic and international market demands.”

Carelabs operates Korea’s No.1 non-face-to-face medical platform ‘Goodoc’ as well as the beauty care information platform ‘Babytalk’. Goodoc and Babytalk, which originated from the Carelabs business division and have experienced rapid growth, were spun off as wholly owned subsidiaries last year and this year, respectively, with the aim of business expansion and maximizing corporate value.

This content was produced with the assistance of AI translation services.